Dr. Bostwick is the Assistant Dean for Co-Curriculum and Professional Development and Clinical Professor of Pharmacy at the University of Michigan College of Pharmacy. She received her PharmD degree from the University of Michigan College of Pharmacy. Following graduation, she completed a specialty residency in psychiatric pharmacy with Kaiser Permanente in Denver, CO. She practiced as a psychiatric pharmacist for 15 years, developing pharmacy services in inpatient and outpatient psychiatry, before transitioning into her current administrative role. Past administrative roles include serving as Associate Chair of the Department of Clinical Pharmacy at the University of Michigan College of Pharmacy. She is the Course Director of the Lifelong Learning course sequence, as well as co-Director of the electives Well-being for Professional Success (P507) and Foundations of Pharmacy Leadership (P617). In addition to the didactic teaching of pharmacy students, Dr. Bostwick serves as a preceptor for pharmacy students and residents. She is an active member of the American Association of Psychiatric Pharmacists (AAPP), currently serving on the AAPP Board of Directors, and has served as past Chair of the Program and Student Committees as well as Annual Meeting Director. Dr. Bostwick is also a member of the Rho Chi Pharmacy Honor Society and has published more than 80 articles and book chapters, largely focusing in psychiatry, teaching, and the role of psychiatric pharmacists.


  • Oversight of Co-curricular Program

  • Oversight of CoP Student Organizations

  • Professional/personal student guidance and well-being

  • Student Professional Concern Note Process

  • Leadership Scholars Program Lead

  • PharmD student academic success

  • PharmD career services

Research Interests

  • Metabolic monitoring in individuals treated with second generation antipsychotic medications

  • Impact of pharmacy services in psychiatry

  • Student mental health and well-being

Selected Publications

  • Haight RJ, Di Polito CN, Payne GH, Bostwick JR, Fulbright A, Lister JF, Williams AM. Psychotropic Stewardship: Advancing Patient Care. Ment Health Clin. 2023;13(2):36-48. doi: 10.9740/mhc.2023.04.036.

  • Dulellari S, Vesey MR, Mason NA, Marshall V, Bostwick JR. Needs assessment and impact of mental health training among pharmacy students. Currents in Pharmacy Teaching and Learning. 2022;14(6):729-736. doi: 10.1016/j.cptl.2022.06.003.

  • Powell KM, Mason NA, Gayar L, Marshall V, Bostwick JR. Impact of a pilot elective course to address student pharmacist well-being. Currents in Pharmacy Teaching and Learning. 2021;13:1464-1470.

  • Harris SC, Bostwick JR, Werremeyer AB, Goldstone LW, Cates ME, Caley CF. Wellness and stigma: pharmacy’s ongoing conflict. Am J Pharm Educ. 2021. Aug;85(7):8354. doi: 10.5688/ajpe8354. Epub 2021 Feb 11.

  • Funk MC, Beach SR, Bostwick JR, Celano CM, Hasnain M, Pandurangi A, Khandai AC, Taylor A, Levenson JL, Riba M, Kovacs RJ. QTc prolongation and psychotropic medications. Am J Psychiatry. 2020;177(3):273-4.

  • Chow CL, Kadouh NK, VandenBerg AM, Bostwick JR. Akathisia in newer second-generation antipsychotic drugs: a review of current evidence. Pharmacotherapy. 2020;40(6):565-574.

  • Silvia RJ, Lee KC, Bostwick JR, Cobb CD, Goldstone LW, Moore TD, Payne GH, Ho JL. Assessment of the current practice of psychiatric pharmacists in the United States. Ment Health Clin [Internet]. 2020;10(6):346-53.

  • Werremeyer A, Bostwick J, Cobb C, Moore TD, Park SH, Price C, et al. Impact of pharmacists on outcomes for patients with psychiatric or neurologic disorders. Ment Health Clin [Internet]. 2020;10(6):358-80. DOI: 10.9740/mhc.2020.11.358

  • Bixby AL, VandenBerg A, Bostwick JR.  Therapeutic controversies with serotonin reuptake inhibitors: to bleed or not to bleed? Annals of Pharmacotherapy. 2018 Aug 6:1060028018794005. doi: 10.1177/1060028018794005. 

  • Dopheide J, Bostwick JR, Goldstone L, Thomas K, Nemire R, Gable K, Cates M, Caballero J, Smith T, Bainbridge J. Curriculum in psychiatry and neurology for pharmacy programs. American Journal of Pharmaceutical Education. 2017;81(7): Article 5925.

  • Funk KA, Bostwick JR. A comparison of the risk of QT prolongation among SSRIs. Annals of Pharmacotherapy. 2013;47(10):1330-41. doi: 10.1177/1060028013501994

  • Jasiak NM, Bostwick JR. Risk of QT/QTc prolongation among newer non-SSRI antidepressants. Annals of Pharmacotherapy. 2014;48(12):1620-8. doi: 10.1177/1060028014550645

  • Lee J, Dalack GW, Casher MI, Eappen SA, Bostwick JR. Persistence of metabolic monitoring for psychiatry inpatients treated with second-generation antipsychotics utilizing a computer-based intervention. Journal of Clinical Pharmacy and Therapeutics 2016;41(2):209-13. doi: 10.1111/jcpt.12368

  • Farhat NM, Bostwick JR, Rockafellow SD. Improving PGY2 ambulatory care residency training in psychiatry. Journal of Pharmacy Practice. 2017 Jan 1: 897190017729598. doi: 10.1177/0897190017729598. [Epub ahead of print].

  • Thomas SJ, Shin M, McInnis MG, Bostwick JR. Monoamine oxidase inhibitors and other antidepressants or stimulants: strategies for the management of treatment-resistant depression. Pharmacotherapy. 2015;35(4):433-9. doi: 10/1002/phar.1576.

  • Bostwick JR, Leung G, Smith TL, Ahmed U, Bainbridge JL, Peyronnet J. Survey highlights the need to expand offerings of introductory pharmacy practice experiences in psychiatry and neurology: benefits and example experiences. Mental Health Clinician [Internet]. 2018;8(1):7-13. DOI: 10.9740/mhc.2018.01.007.